- Home
- REG vs ICLR Comparison
REG vs ICLR Comparison
Compare REG & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REG | ICLR |
|---|---|---|
| Founded | 1963 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 14.3B |
| IPO Year | 1993 | 1998 |
Fundamental Metrics
Financial Performance| Metric | REG | ICLR |
|---|---|---|
| Price | $68.08 | $184.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | $78.90 | ★ $201.23 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 10-28-2025 | 10-22-2025 |
| Dividend Yield | ★ 4.46% | N/A |
| EPS Growth | ★ 2.61 | N/A |
| EPS | 2.18 | ★ 7.47 |
| Revenue | $1,576,868,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $3.11 | N/A |
| Revenue Next Year | $4.13 | $0.76 |
| P/E Ratio | $31.09 | ★ $24.96 |
| Revenue Growth | ★ 5.84 | N/A |
| 52 Week Low | $63.44 | $125.10 |
| 52 Week High | $78.18 | $228.29 |
Technical Indicators
Market Signals| Indicator | REG | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 39.20 | 56.92 |
| Support Level | $67.10 | $178.80 |
| Resistance Level | $68.95 | $191.85 |
| Average True Range (ATR) | 0.95 | 7.83 |
| MACD | -0.20 | 0.92 |
| Stochastic Oscillator | 22.90 | 73.09 |
Price Performance
Historical ComparisonAbout REG Regency Centers Corporation
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.